{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:29:49Z","timestamp":1791811789707,"version":"4.3.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Previous studies have demonstrated that inflammation-related interleukin-17 (IL-17) signaling plays a pivotal role in the pathogenesis of non-alcoholic steatohepatitis (NASH)- and alcoholic liver disease (ALD)-induced hepatocellular carcinoma (HCC). However, rare efforts have been intended at implementing the analysis of N6-methyladenosine (m6A) mRNA methylation to elucidate the underpinning function of the IL-17 receptor A (IL-17RA) during the inflammation-carcinogenesis transformation of HCC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed methylated RNA immunoprecipitation sequencing (MeRIP-seq) using normal, HCC tumor and paired tumor adjacent tissues from patients to investigate the dynamic changes of m6A mRNA methylation in the process of HCC. Additionally, murine non-alcoholic fatty liver disease (NAFLD) model and murine chronic liver injury model were utilized to investigate the role of IL-17RA regulated by m6A mRNA modulator fat mass and obesity-associated (FTO) in chronic hepatic inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>MeRIP-seq revealed the reduction of m6A mRNA methylation of IL-17RA in tumor adjacent tissues with chronic inflammation, suggesting the potential role of IL-17RA in the inflammation-carcinogenesis transformation of HCC. Besides, we demonstrated that FTO, rather than methyltransferase-like 3 (METTL3), methyltransferase-like 14 (METTL14), and alkB homolog 5 (ALKBH5) functions as a main modulator for the decrease of m6A mRNA methylation of IL-17RA <jats:italic>via<\/jats:italic> knockdown and overexpression of FTO <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Overall, we elaborated the underlying mechanisms of the increase of IL-17RA resulting in chronic inflammation <jats:italic>via<\/jats:italic> the demethylation of FTO in tumor adjacent tissues and demonstrated that targeting the specific m6A modulator FTO may provide an effective treatment for hepatitis patients to prevent the development of HCC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.989353","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T07:34:32Z","timestamp":1662968072000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaojie","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2019.06.021","article-title":"Pas de deux: Control of anti-tumor immunity by cancer-associated inflammation","volume":"51","author":"Shalapour","year":"2019","journal-title":"Immunity"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: Triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(88)80138-9","article-title":"Rudolf Virchow and modern aspects of tumor pathology","volume":"183","author":"David","year":"1988","journal-title":"Pathol Res Pract"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2174\/138161209788453167","article-title":"Inflammation, microenvironment, and the immune system in cancer progression","volume":"15","author":"Keibel","year":"2009","journal-title":"Curr Pharm Des"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann Afr Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-00459-9","article-title":"Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age","volume":"18","author":"Hou","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s40425-019-0749-z","article-title":"Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response","volume":"7","author":"Keenan","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.01.012","article-title":"Liver inflammation and hepatobiliary cancers","volume":"7","author":"Leone","year":"2021","journal-title":"Trends Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nature18298","article-title":"Corrigendum: Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex","volume":"534","author":"Wang","year":"2016","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201744940","article-title":"Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRNAs and various non-coding RNAs","volume":"18","author":"Warda","year":"2017","journal-title":"EMBO Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1101\/gad.309146.117","article-title":"Zc3h13\/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15\/Spenito to the m(6)A machinery component Wtap\/Fl(2)d","volume":"32","author":"Knuckles","year":"2018","journal-title":"Genes Dev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","article-title":"VIRMA mediates preferential m(6)A mRNA methylation in 3\u2019UTR and near stop codon and associates with alternative polyadenylation","volume":"4","author":"Yue","year":"2018","journal-title":"Cell Discovery"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature19342","article-title":"m(6)A RNA methylation promotes XIST-mediated transcriptional repression","volume":"537","author":"Patil","year":"2016","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.05.175","article-title":"m(6)A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression","volume":"502","author":"Liu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","article-title":"m(6)A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program","volume":"31","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"12626","DOI":"10.1038\/ncomms12626","article-title":"YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex","volume":"7","author":"Du","year":"2016","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.15","article-title":"YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA","volume":"27","author":"Shi","year":"2017","journal-title":"Cell Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007412","article-title":"Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development","volume":"14","author":"Kasowitz","year":"2018","journal-title":"PloS Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.99","article-title":"Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis","volume":"27","author":"Hsu","year":"2017","journal-title":"Cell Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ab.2019.05.005","article-title":"Role of identified RNA N6-methyladenosine methylation in liver","volume":"578","author":"Xu","year":"2019","journal-title":"Anal Biochem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3390\/nu10111600","article-title":"Fat mass and obesity associated (FTO) gene and hepatic glucose and lipid metabolism","volume":"10","author":"Mizuno","year":"2018","journal-title":"Nutrients"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.26746","article-title":"FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation","volume":"119","author":"Kang","year":"2018","journal-title":"J Cell Biochem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.50003","article-title":"The emerging roles of m(6)A modification in liver carcinogenesis","volume":"17","author":"Pan","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s11658-020-00204-1","article-title":"GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation","volume":"25","author":"Ding","year":"2020","journal-title":"Cell Mol Biol Lett"},{"key":"B28","doi-asserted-by":"publisher","first-page":"102429","DOI":"10.1016\/j.autrev.2019.102429","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies","volume":"19","author":"Ruiz de Morales","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B29","article-title":"Th17 and IL-17 immunity in chronic hepatitis c infection","volume":"50","author":"Balanescu","year":"2012","journal-title":"Rom J Intern Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1746-1596-8-40","article-title":"Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis b virus infection: IL-17 in HBV infection","volume":"8","author":"Du","year":"2013","journal-title":"Diagn Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22680","article-title":"The interleukin-17 pathway is involved in human alcoholic liver disease","volume":"49","author":"Lemmers","year":"2009","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.01.006","article-title":"IL-17 signaling: The yin and the yang","volume":"38","author":"Amatya","year":"2017","journal-title":"Trends Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.06.008","article-title":"IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases","volume":"17","author":"Beringer","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i28.3696","article-title":"Lentiviral vector-mediated down-regulation of IL-17A receptor in hepatic stellate cells results in decreased secretion of IL-6","volume":"18","author":"Zhang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.12.016","article-title":"IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease","volume":"72","author":"Ma","year":"2020","journal-title":"J Hepatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2006092","article-title":"Refined RIP-seq protocol for epitranscriptome analysis with low input materials","volume":"16","author":"Zeng","year":"2018","journal-title":"PloS Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and liver cancer: Molecular mechanisms and therapeutic targets","volume":"39","author":"Yang","year":"2019","journal-title":"Semin Liver Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1021\/ja3064149","article-title":"Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor","volume":"134","author":"Chen","year":"2012","journal-title":"J Am Chem Soc"},{"key":"B41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12967-020-02417-6","article-title":"Overview of distinct 5-methylcytosine profiles of messenger RNA in human hepatocellular carcinoma and paired adjacent non-tumor tissues","volume":"18","author":"Zhang","year":"2020","journal-title":"J Transl Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2019-0365","article-title":"Dynamic analysis of m6A methylation spectroscopy during progression and reversal of hepatic fibrosis","volume":"12","author":"Cui","year":"2020","journal-title":"Epigenomics"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2019-0009","article-title":"Comprehensive analysis of differences of N(6)-methyladenosine RNA methylomes between high-fat-fed and normal mouse livers","volume":"11","author":"Luo","year":"2019","journal-title":"Epigenomics"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04471.x","article-title":"Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease","volume":"166","author":"Tang","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2174\/1389450116666150531153627","article-title":"IL-17 axis driven inflammation in non-alcoholic fatty liver disease progression","volume":"16","author":"Giles","year":"2015","journal-title":"Curr Drug Targets"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.09.086","article-title":"Hepatic FTO expression is increased in NASH and its silencing attenuates palmitic acid-induced lipotoxicity","volume":"479","author":"Lim","year":"2016","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.989353\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T07:34:40Z","timestamp":1662968080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.989353\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":46,"alternative-id":["10.3389\/fonc.2022.989353"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.989353","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,12]]},"article-number":"989353"}}